MarketPeel
Insider Trading Intelligence
Pricing
…
IE

Idan Elmelech

BBOT
COO & PRINCIPAL FINANCIAL OFCR · BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. · CIK 0002058437
FILING MIX · LIFETIME50%/50%
BUYS
1
SELLS
1
TOTAL VALUE
$2.7K
COMPANIES
1
ACTIVE SINCE
May 2026
HOLDINGS NOW
14,495
AVG SELL PX
$7.80
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Idan Elmelech. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
BBOT · 14,495 shares · as of Jul 1, 2026
0189,556379,111568,667758,222SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
2026
FLOW · 1 buys / 1 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
SALE
COO & Principal Financial Ofcr
343$7.80$2.7K14,495Jul 1, 2026Jul 6, 2026 ↗View →
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
758,222——758,222May 10, 2026May 12, 2026 ↗View →
Other insiders · BBOT
Loading peer insiders…
About this filer
CIK 0002058437
ROLE
COO & Principal Financial Ofcr
PRIMARY
BBOT
COMPANIES
1
ACTIVE SINCE
May 2026
MARKETPEEL · /INSIDER/0002058437DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback